Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 31, 2019 - Issue 3
241
Views
7
CrossRef citations to date
0
Altmetric
Articles

Trajectory of use over time of an oral tablet and a rectal gel for HIV prevention among transgender women and men who have sex with men

, ORCID Icon, , , , , , , , & show all
Pages 379-387 | Received 14 Nov 2017, Accepted 27 Sep 2018, Published online: 14 Oct 2018

References

  • Ammassari, A., Trotta, M., Murri, R., Castelli, F., Narciso, P., & Noto, P. … AdICoNA Study Group. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. JAIDS Journal of Acquired Immune Deficiency Syndromes, 31(Suppl. 3), S123–S127. doi: 10.1097/00126334-200212153-00007
  • Bauermeister, J., Giguere, R., Dolezal, C., Leu, C. S., Febo, I., Cranston, R. D., … Carballo-Diéguez, A. (2016). To use a rectal microbicide, first insert the applicator: Gel and applicator satisfaction among young men who have sex with men. AIDS Education and Prevention, 28(1), 1–10. doi: 10.1521/aeap.2016.28.1.1
  • Bauermeister, J. A., Giguere, R., Leu, C. S., Dolezal, C., Febo, I., Cranston, R. D., … Carballo-Diéguez, A. (2017). Patterns of a rectal microbicide placebo gel use in a preparatory stage for a phase I trial among young men who have sex with men. AIDS and Behavior, 22(2), 412–420. doi: 10.1007/s10461-017-1847-x
  • Brose, A., Scheibe, S., & Schmiedek, F. (2013). Life contexts make a difference: Emotional stability in younger and older adults. Psychology and Aging, 28(1), 148–159. doi: 10.1037/a0030047
  • Carballo-Diéguez, A., Giguere, R., Dolezal, C., Leu, C.-S., Balán, I., Brown IIIW., … Cranston, R. D. (2017). Preference of oral tenofovir disoproxil fumarate/emtricitabine versus rectal tenofovir reduced-glycerin 1% gel regimens for HIV prevention among cisgender men and transgender women who engage in receptive anal intercourse with men. AIDS and Behavior, 21(12), 3336–3345. doi: 10.1007/s10461-017-1969-1
  • Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124–133. doi: 10.1037/0278-6133.19.2.124
  • Corneli, A. L., Deese, J., Wang, M., Taylor, D., Ahmed, K., Agot, K., … Van Damme, L. (2014). FEM-PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(3), 324–331. doi: 10.1097/QAI.0000000000000158
  • Cranston, R. D., Lama, J. R., Richardson, B. A., Carballo-Diéguez, A., Kunjara Na Ayudhya, R. P., Liu, K., … MTN-017 Protocol Team. (2017). MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel. Clinical Infectious Diseases, 64(5), 614–620.
  • Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., … Mulligan, K. (2015). HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e512–e519. doi: 10.1016/S2352-3018(15)00206-4
  • Glass, T., Battegay, M., Cavassini, M., De Geest, S., Furrer, H., & Vernazza, P., … Swiss HIV Cohort Study. (2010). Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes, 54(2), 197–203.
  • Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults. Aids (London, England), 18(1), 19–25. doi: 10.1097/00002030-200401001-00004
  • Leu, C. S., Mabragaña, M., Giguere, R., Dolezal, C., Carballo-Diéguez, A., & McGowan, I. (2013). Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007). AIDS and Behavior, 17(9), 3101–3107. doi: 10.1007/s10461-013-0549-2
  • Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., & Nair, G. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
  • Rees, H., Delany-Moretlwe, S., Lombard, C., Baron, D., Panchia, R., Myer, L., … Gray, G. (2015). FACTS 001 Phase III trial of pericoital tenofovir 1% gel for HIV prevention in women. In Conference on Retroviruses and Opportunistic Infections (CROI). Retrieved from http://www.croiconference.org/sessions/facts-001-phase-iii-trial-pericoital-tenofovir-1-gel-hiv-prevention-women
  • Sineath, R. C., Finneran, C., Sullivan, P., Sanchez, T., Smith, D. K., Griensven, F. V., … Stephenson, R. (2013). Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand. Journal of the International Association of Providers of AIDS Care (JIAPAC), 12(4), 227–231. doi: 10.1177/2325957413488184
  • Tolley, E. E., Harrison, P. F., Goetghebeur, E., Morrow, K., Pool, R., Taylor, D., … van der Straten, A. (2010). Adherence and its measurement in phase 2/3 microbicide trials. AIDS and Behavior, 14(5), 1124–1136. doi: 10.1007/s10461-009-9635-x
  • Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422. doi: 10.1056/NEJMoa1202614
  • van der Straten, A., Shiboski, S., Montgomery, E. T., Moore, J., Bruyn, G. D., Ramjee, G., … Padian, N. (2009). Patterns and predictors of adherence to diaphragm use in a phase III trial in Sub-Saharan Africa: A trajectory analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50(4), 419–426. doi: 10.1097/QAI.0b013e3181958511

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.